The formation and persistence of carboplatin-DNA adducts in rats

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 3, 1996, Pages 273-280

  Blommaert, Frank A ^a   Michael, Charulla ^a   Van Dijk Knijnenburg, Helma C M ^b   Schornagel, Jan H ^a   Den Engelse, Leo ^a   Fichtinger Schepman, Anne Marie J ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Carboplatin; DNA adducts; ELISA; Immunocytochemistry; Rats

Indexed keywords

CARBOPLATIN; CISPLATIN; DNA; PLATINUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOCHEMISTRY; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; MALE; NONHUMAN; OVARY; PRIORITY JOURNAL; RAT; SPLEEN; TESTIS; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; CARBOPLATIN; DNA ADDUCTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; KIDNEY CORTEX; LIVER; MALE; MUTAGENS; OVARY; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TESTIS; UTERUS;

EID: 0029894976     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050482     Document Type: Article

References (32)

1. Aggarwal SK (1993) A histochemical approach to the mechanism of action of cisplatin and its analogues. J Histochem Cytochem 41:1053
2. Blommaert FA, Michael C, Terheggen PMAB, Muggia FM, Kortes V, Schornagel JH, Hart AAM, Engelse L den (1993) Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method - interindividual variation and correlation with disease response. Cancer Res 53:5669
3. Blommaert FA, Dijk-Knijnenburg HCM van, Dijt FJ, Engelse L den, Baan RA, Berends F, Fichtinger-Schepman AMJ (1995) Formation of DNA adducts by the anticancer drug carboplalin: different nucleotide sequence preferences in vitro and in cells. Biochemistry 34:8474
4. Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E (1982) Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9:140
5. Calvert AH, Horwich A, Newlands ES, Begent R, Rustin G, Kaye SB, Williams CJ, Harris AL, Slevin ML (1988) Carboplatin or cisplatin? Lancet II: 577
6. Cleare MJ, Hydes PC, Malerbi BW, Watkins DM (1978) Antitumour platinum complexes: relationships between chemical properties and activity. Biochimie 60:835
7. Courjault F, Leroy D, Coquery I, Toutain H (1993) Platinum complex-induced dysfunction of cultured renal proximal tubule cells - a comparative study of carboplatin and transplatin with cisplatin. Arch Toxicol 67:338
8. Den Engelse L, Schornagel J, Blommaert FA, Terheggen PMAB (1991) Immunocytochemical analysis of platinum-DNA adducts. In: Howell SB (ed) Proceedings of the VIth international symposium on platinum and other metal coordination compounds in cancer chemotherapy, January 23-26, San Diego, California. Plenum, New York, p 285
9. Fichtinger-Schepman AMJ, Veer JL van der, Lohman PHM, Reedijk J (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 24:707
10. Fichtinger-Schepman AMJ, Baan RA, Luiten SA, Dijk M van, Lohman PHM (1985) Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum(II) and analysis of adduct-related DNA unwinding. Chem Biol Interact 55:275
11. Fichtinger-Schepman AMJ, Oosterom AT van, Lohman PHM, Berends F (1987) cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res 47:3000
12. Fichtinger-Schepman AMJ, Vendrik CPJ, Dijk-Knijnenburg WCM van, Jong WH de, Minnen ACE van der, Claessen AME, Velde-Visser SD van der, Groot G de (1989) Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma. Cancer Res 49:2862
13. Gill I, Muggia FM, Terheggen PM, Michael C, Parker RJ, Kortes V, Grunberg S, Christian MC, Reed E, Engelse L den (1991) Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum-DNA adducts. Ann Oncol 2:115
14. Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Schepman AMJ, Shellard SA (1994) Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. Eur J Cancer 30A:832
15. Howell SB (ed) (1991) Proceedings of the VIth international symposium on platinum and other metal coordination compounds in cancer chemotherapy, January 23-26, San Diego, California. Plenum, New York
16. Huang JC, Zamble DB, Reardon JT, Lippard SJ, Sancar A (1994) HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc Natl Acad Sci USA 91:10394
17. Knox RJ, Friedlos F, Lydall DA, Roberts JJ (1986) Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Res 46:1972
18. Los G, Verdegaal E, Noteborn HP, Ruevekamp M, Graeff A de, Meesters EW, Bokkel Huinink WW ten, McVie JG (1991) Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action. Biochem Pharmacol 42:357
19. Meeuwsen F (1986) A new plastic (K-plast) based on methylmethacrylate for light microscopy. Histotechniek/NL 3:77
20. Page JD, Husain I, Sancar A, Chaney SG (1990) Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair and lethality. Biochemistry 29:1016
21. Poirier MC, Reed E, Litterst CL, Katz L, Gupta BS (1992) Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res 52:149
22. 0 toward the major groove. Proc Natl Acad Sci USA 85:4158
23. Rodenhuis S, Vlasveld LT, Dubbelman R, Roodbergen R, Schornagel JH, Wanders J, Israels SP, Bais E, Bokkel Huinink WW ten, Richel DJ (1992) Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancer. Ann Oncol 3:463
24. Siddik ZH, Jones M, Boxall FE, Harrap KR (1988) Comparative distribution and excretion of carboplatin and cisplatin in mice. Cancer Chemother Pharmacol 21:19
25. Tay K, Bregman CL, Masters BA, Williams PD (1988) Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 48:2538
26. Terheggen PMAB, Floot BGJ, Scherer E, Begg AC, Fichtinger-Schepman AMJ, Engelse L den (1987) Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II) with DNA in rodent tissue sections. Cancer Res 47:6719
27. Terheggen PMAB, Emondt JY, Floot BGJ, Dijkman R, Schrier PI, Engelse L den, Begg AC (1990) Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiscrum. Cancer Res 50:3556
28. Terheggen PMAB, Begg AC, Emondt JY, Dubbelman R, Floot BGJ, Engelse L den (1991) Formation of interaction products of carboplatin with DNA in vitro and in cancer patients. Br J Cancer 63:195
29. Terheggen PMAB, Floot BG, Lempers EL, Tellingen O van, Begg AC, Engelse L den (1991) Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides. Cancer Chemother Pharmacol 28:185
30. Tonetti M, Giovine M, Gasparini A, Benatti U, Deflora A (1993) Enhanced formation of reactive species from cis-diammine-(1,1-cyclobutanedicarboxylato)-platinum(II) (carboplatin) in the presence of oxygen free radicals. Biochem Pharmacol 46:1377
31. Van Benthem J, Wild CP, Vermeulen E, Engelse L den, Scherer E (1991) Immunocytochemical localization of DNA adducts induced by a single dose of N-nitroso-N-methylbenzylamine in target and non-target tissues of tumor formation in the rat. Carcinogenesis 12:1831.
32. Visse R, Gool AJ van, Moolenaar GF, Ruijter M de, Putte P van de (1994) The actual incision determines the efficiency of repair of cisplatin-damaged DNA by the Escherichia coli UvrABC endonuclease. Biochemistry 33:1804